Vaginal cancer classification

Revision as of 13:11, 5 February 2019 by Syed Musadiq Ali (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Vaginal cancer Microchapters


Patient Information


Historical Perspective




Differentiating Vaginal cancer from other Diseases

Epidemiology and Demographics

Risk Factors


Natural History, Complications and Prognosis


History and Symptoms

Physical Examination


Laboratory Findings

X Ray




Other Imaging Findings

Other Diagnostic Studies


Medical Therapy


Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Vaginal cancer classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides


American Roentgen Ray Society Images of Vaginal cancer classification

All Images
Echo & Ultrasound
CT Images

Ongoing Trials at Clinical

US National Guidelines Clearinghouse

NICE Guidance

FDA on Vaginal cancer classification

CDC on Vaginal cancer classification

Vaginal cancer classification in the news

Blogs on Vaginal cancer classification

Directions to Hospitals Treating Vaginal cancer

Risk calculators and risk factors for Vaginal cancer classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Syed Musadiq Ali M.B.B.S.[2]


Vaginal cancer may be classified according to histopathology into squamous cell carcinoma, adenocarcinoma, vaginal sarcoma and melanoma.

Types of vaginal cancer

Types of vaginal cancer, in order of prevalence, include:

  • Vaginal squamous cell carcinoma:
  • Vaginal adenocarcinoma:
  • Vaginal sarcoma:



  1. 1.0 1.1 Creasman WT, Phillips JL, Menck HR (September 1998). "The National Cancer Data Base report on cancer of the vagina". Cancer. 83 (5): 1033–40. PMID 9731908.
  2. Ikenberg H, Runge M, Göppinger A, Pfleiderer A (September 1990). "Human papillomavirus DNA in invasive carcinoma of the vagina". Obstet Gynecol. 76 (3 Pt 1): 432–8. PMID 2166263.
  3. Isaacs JH (September 1976). "Verrucous carcinoma of the female genital tract". Gynecol. Oncol. 4 (3): 259–69. PMID 964693.
  4. Herbst AL, Ulfelder H, Poskanzer DC (April 1971). "Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women". N. Engl. J. Med. 284 (15): 878–81. doi:10.1056/NEJM197104222841604. PMID 5549830.
  5. Hanselaar AG, Van Leusen ND, De Wilde PC, Vooijs GP (April 1991). "Clear cell adenocarcinoma of the vagina and cervix. A report of the Central Netherlands Registry with emphasis on early detection and prognosis". Cancer. 67 (7): 1971–8. PMID 2004313.
  6. Verloop J, Rookus MA, van Leeuwen FE (June 2000). "Prevalence of gynecologic cancer in women exposed to diethylstilbestrol in utero". N. Engl. J. Med. 342 (24): 1838–9. doi:10.1056/NEJM200006153422415. PMID 10866558.
  7. Hilgers RD, Malkasian GD, Soule EH (June 1970). "Embryonal rhabdomyosarcoma (botryoid type) of the vagina. A clinicopathologic review". Am. J. Obstet. Gynecol. 107 (3): 484–502. PMID 4915719.
  8. DeMatos P, Tyler D, Seigler HF (July 1998). "Mucosal melanoma of the female genitalia: a clinicopathologic study of forty-three cases at Duke University Medical Center". Surgery. 124 (1): 38–48. PMID 9663250.
  9. Frumovitz M, Etchepareborda M, Sun CC, Soliman PT, Eifel PJ, Levenback CF, Ramirez PT (December 2010). "Primary malignant melanoma of the vagina". Obstet Gynecol. 116 (6): 1358–65. doi:10.1097/AOG.0b013e3181fb8045. PMID 21099603.